Pfizer
Patents, Design & Utilities
Last updated:
List of all Pfizer patents 451 in total
| Status | Patent |
|---|---|
Application | Utility: TOLL-LIKE RECEPTOR AGONISTS Filling date: 13 Sep 2025 Issue date: 21 Jan 2021 |
Application | Utility: CELLS AND METHOD OF CELL CULTURE Filling date: 13 Sep 2025 Issue date: 21 Jan 2021 |
Application | Utility: PYRIDINONE AND PYRIMIDINONE PHOSPHATES AND BORONATES USEFUL AS ANTIBACTERIAL AGENTS Filling date: 13 Sep 2025 Issue date: 21 Jan 2021 |
Application | Utility: Fluoro-Pyridinone Phosphates And Boronates Useful As Antibacterial Agents Filling date: 13 Sep 2025 Issue date: 21 Jan 2021 |
Application | Utility: Antibody Purification Filling date: 13 Sep 2025 Issue date: 21 Jan 2021 |
Grant | Utility: Stable aqueous anti-vascular endothelial growth factor (VEGF) antibody formulation Filling date: 13 Sep 2025 Issue date: 19 Jan 2021 |
Application | Utility: MANUFACTURING PROCESS AND INTERMEDIATES FOR A PYRROLO[2,3-D]PYRIMIDINE COMPOUND AND USE THEREOF Filling date: 13 Sep 2025 Issue date: 14 Jan 2021 |
Application | Utility: SOLUBLE FGFR3 DECOYS FOR TREATING SKELETAL GROWTH DISORDERS Filling date: 13 Sep 2025 Issue date: 14 Jan 2021 |
Grant | Utility: Neisseria meningitidis compositions and methods thereof Filling date: 13 Sep 2025 Issue date: 12 Jan 2021 |
Application | Utility: Bruton's Tyrosine Kinase Inhibitors Filling date: 13 Sep 2025 Issue date: 7 Jan 2021 |
Application | Utility: COMPOSITIONS AND METHODS FOR COUNTERACTING FACTOR XA INHIBITION Filling date: 13 Sep 2025 Issue date: 7 Jan 2021 |
Application | Utility: ANTI-PD-1 ANTIBODY COMPOSITIONS Filling date: 13 Sep 2025 Issue date: 7 Jan 2021 |
Application | Utility: COMBINATION OF AN ANTI-PD-L1 ANTIBODY AND IDO1 INHIBITOR FOR THE TREATMENT OF CANCER Filling date: 13 Sep 2025 Issue date: 7 Jan 2021 |
Application | Utility: NEISSERIA MENINGITIDIS COMPOSITIONS AND METHODS THEREOF Filling date: 13 Sep 2025 Issue date: 31 Dec 2020 |
Application | Utility: IMMUNOGENIC COMPOSITIONS FOR USE IN PNEUMOCOCCAL VACCINES Filling date: 13 Sep 2025 Issue date: 31 Dec 2020 |
Application | Utility: COMBINATION OF A CYCLIN DEPENDENT KINASE INHIBITOR AND A BET- BROMODOMAIN INHIBITOR Filling date: 13 Sep 2025 Issue date: 31 Dec 2020 |
Grant | Utility: Tissue factor pathway inhibitor antibodies and uses thereof Filling date: 13 Sep 2025 Issue date: 29 Dec 2020 |
Grant | Utility: Anti-CXCR5 antibodies and compositions and uses thereof Filling date: 13 Sep 2025 Issue date: 29 Dec 2020 |
Application | Utility: PYRAZOLO[1,5-A]PYRAZIN-4-YL DERIVATIVES Filling date: 13 Sep 2025 Issue date: 24 Dec 2020 |
Application | Utility: Benzisoxazole Sulfonamide Derivatives Filling date: 13 Sep 2025 Issue date: 24 Dec 2020 |
Grant | Utility: PD-L1 antagonist combination treatments Filling date: 13 Sep 2025 Issue date: 22 Dec 2020 |
Grant | Utility: Bifunctional cytotoxic agents containing the CTI pharmacophore Filling date: 13 Sep 2025 Issue date: 22 Dec 2020 |
Application | Utility: CDK2/4/6 Inhibitors Filling date: 13 Sep 2025 Issue date: 17 Dec 2020 |
Application | Utility: MUTEINS OF CLOTTING FACTOR Vlll Filling date: 13 Sep 2025 Issue date: 17 Dec 2020 |
Grant | Utility: Heterocyclic spiro compounds as MAGL inhibitors Filling date: 13 Sep 2025 Issue date: 8 Dec 2020 |
Application | Utility: SUBSTITUTED 3-AZABICYCLO[3.1.0]HEXANES AS KETOHEXOKINASE INHIBITORS Filling date: 13 Sep 2025 Issue date: 3 Dec 2020 |
Application | Utility: Bicyclic-Fused Heteroaryl or Aryl Compounds Filling date: 13 Sep 2025 Issue date: 3 Dec 2020 |
Application | Utility: SITE SPECIFIC HER2 ANTIBODY DRUG CONJUGATES Filling date: 13 Sep 2025 Issue date: 3 Dec 2020 |
Application | Utility: APIXABAN FORMULATIONS Filling date: 13 Sep 2025 Issue date: 3 Dec 2020 |
Grant | Utility: GLP-1 receptor agonists and uses thereof Filling date: 13 Sep 2025 Issue date: 1 Dec 2020 |
Grant | Utility: Anti-proliferative agents for treating PAH Filling date: 13 Sep 2025 Issue date: 1 Dec 2020 |
Grant | Utility: Tissue-specific genome engineering using CRISPR-Cas9 Filling date: 13 Sep 2025 Issue date: 1 Dec 2020 |
Grant | Utility: Dosage regimen for MAdCAM antagonists Filling date: 13 Sep 2025 Issue date: 1 Dec 2020 |
Application | Utility: Immunogenic Compositions and Uses Thereof Filling date: 13 Sep 2025 Issue date: 26 Nov 2020 |
Application | Utility: PD-1/PD-L1 INHIBITORS FOR THE TREATMENT OF CANCER Filling date: 13 Sep 2025 Issue date: 19 Nov 2020 |
Grant | Utility: Reagents for fluorosulfating alcohols or amines Filling date: 13 Sep 2025 Issue date: 17 Nov 2020 |
Application | Utility: CYCLIN DEPENDENT KINASE INHIBITORS Filling date: 13 Sep 2025 Issue date: 12 Nov 2020 |
Application | Utility: Crystalline 2-Amino-2-(Hydroxymethyl)Propane-1,3-Diol Salt of 4-(4-(1-Isopropyl-7-OXO-1,4,6,7-tetrahydrospiro[indazole-5,4'-piperidine]- -1'-carbonyl)-6-methoxypryridin-2-YL)benzoic acid Filling date: 13 Sep 2025 Issue date: 12 Nov 2020 |
Grant | Utility: Neisseria meningitidis composition and methods thereof Filling date: 13 Sep 2025 Issue date: 10 Nov 2020 |
Grant | Utility: Interferon beta antibodies and uses thereof Filling date: 13 Sep 2025 Issue date: 10 Nov 2020 |
Grant | Utility: N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors Filling date: 13 Sep 2025 Issue date: 3 Nov 2020 |
Grant | Utility: RSV F protein mutants Filling date: 13 Sep 2025 Issue date: 3 Nov 2020 |
Grant | Utility: Pyrazolo[1,5-a]pyrazin-4-yl derivatives Filling date: 13 Sep 2025 Issue date: 3 Nov 2020 |
Grant | Utility: Neisseria meningitidis compositions and methods thereof Filling date: 13 Sep 2025 Issue date: 27 Oct 2020 |
Grant | Utility: Manufacturing process and intermediates for a pyrrolo[2,3-d]pyrimidine compound and use thereof Filling date: 13 Sep 2025 Issue date: 27 Oct 2020 |
Grant | Utility: Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR Filling date: 13 Sep 2025 Issue date: 27 Oct 2020 |
Grant | Utility: Bruton's tyrosine kinase inhibitors Filling date: 13 Sep 2025 Issue date: 27 Oct 2020 |
Application | Utility: GLYCOCONJUGATION PROCESS Filling date: 13 Sep 2025 Issue date: 22 Oct 2020 |
Application | Utility: AMINOPYRIMIDINYL COMPOUNDS Filling date: 13 Sep 2025 Issue date: 22 Oct 2020 |
Application | Utility: ANTI-PROLIFERATIVE AGENTS FOR TREATING PAH Filling date: 13 Sep 2025 Issue date: 22 Oct 2020 |
Showing 200 to 250 of 451 patents.